Patient's weight can decide about spending millions on enzyme replacement therapy in MPS II

Mol Genet Metab Rep. 2015 Dec 18:6:5-7. doi: 10.1016/j.ymgmr.2015.12.002. eCollection 2016 Mar.
No abstract available

Keywords: Enzyme replacement; Expensive therapies; MPS, mucopolysaccharidosis; Pediatric orphan disease; Public health; Walking test.